2.6
2023

Contact sensitization in pediatric patients with atopic dermatitis: a purpose for a new patch testing series for the Portuguese population

Show more: Authors information and Publication history
Authors Information

1Department of Allergy and Clinical Immunology, Coimbra University Hospital Center, Coimbra, Portugal2Department of Pediatric, Coimbra University Hospital Center, Coimbra, Portugal
3Department of Dermatology, Coimbra University Hospital Center, Coimbra, Portugal
4Department of Dermatology, Faculty of Medicine, University of Coimbra, Coimbra, Portugal

History

Published: 09 June 2022
Accepted: 09 June 2022
Received: 16 May 2022

SUMMARY

Background. Atopic dermatitis is a prevalent condition in the pediatric population, with affected children exhibiting a susceptibility to cutaneous sensitization due to skin barrier dysfunction and immune dysregulation. Recent studies have highlighted an increased prevalence of certain allergens, which identifi­cation may be clinically relevant, with direct implications for the management of atopic dermatitis. Methods. We retrospective reviewed pediatric patients patch tested due to suspected contact dermatitis. Patients were divided according the diagnosis of AD, with subsequent comparison of positive results for both groups. Results. A total of 145 pediatric patch testing were analyzed, 44.1% (n = 63) with the diagnosis of atopic dermatitis. There were notable differences in sensitization rates of relevant allergens between groups and when compared to other European studies. Based on the most prevalent and relevant allergens, we proposed a tailored hapten series for assessing portuguese pediatric patients with AD and suspected allergic contact dermatitis. Conclusions. Our findings confirmed the geograph­ic sensitization variability and emphasize the need for pediatric adaptation and “individualized baseline series”.

KEY WORDS
Atopic dermatitis; allergic contact dermatitis; prevalent allergens; baseline serie; pediatric patients.

Table of Content: Vol. 56 (No. 1) 2024 January

European Annals of Allergy and Clinical Immunology ISSN 1764-1489 | © 2024